159 related articles for article (PubMed ID: 38488994)
21. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.
Pessina F; Navarria P; Cozzi L; Tomatis S; Riva M; Ascolese AM; Santoro A; Simonelli M; Bello L; Scorsetti M
J Neurooncol; 2017 Jan; 131(2):377-384. PubMed ID: 27826681
[TBL] [Abstract][Full Text] [Related]
22. Repeat-surgery at Glioblastoma recurrence, when and why to operate?
Ening G; Huynh MT; Schmieder K; Brenke C
Clin Neurol Neurosurg; 2015 Sep; 136():89-94. PubMed ID: 26092644
[TBL] [Abstract][Full Text] [Related]
23. Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.
Mampre D; Ehresman J; Pinilla-Monsalve G; Osorio MAG; Olivi A; Quinones-Hinojosa A; Chaichana KL
Br J Neurosurg; 2018 Oct; 32(5):528-535. PubMed ID: 30073866
[TBL] [Abstract][Full Text] [Related]
24. Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era.
Ortega A; Sarmiento JM; Ly D; Nuño M; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2016 Feb; 24():105-11. PubMed ID: 26671314
[TBL] [Abstract][Full Text] [Related]
25. Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.
Yong RL; Wu T; Mihatov N; Shen MJ; Brown MA; Zaghloul KA; Park GE; Park JK
J Neurosurg; 2014 Oct; 121(4):802-9. PubMed ID: 25061868
[TBL] [Abstract][Full Text] [Related]
26. Intraoperative radiotherapy in recurrent IDH-wildtype glioblastoma with gross total resection: A single-center retrospective study.
Bao H; Ai S; Wang G; Yi L; Lai J; Wang S; Lv Z; Li C; Liu Q; Zhao X; Wu C; Liu C; Mi S; Sun X; Hao C; Liang P
Clin Neurol Neurosurg; 2024 Jan; 236():108103. PubMed ID: 38199118
[TBL] [Abstract][Full Text] [Related]
27. Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma.
Seyve A; Lozano-Sanchez F; Thomas A; Mathon B; Tran S; Mokhtari K; Giry M; Marie Y; Capelle L; Peyre M; Carpentier A; Feuvret L; Sanson M; Hoang-Xuan K; Honnorat J; Delattre JY; Ducray F; Idbaih A
Clin Neurol Neurosurg; 2020 Sep; 196():106006. PubMed ID: 32554237
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival.
Delgado-Fernandez J; Garcia-Pallero MÁ; Blasco G; Penanes JR; Gil-Simoes R; Pulido P; Sola RG
World Neurosurg; 2017 Dec; 108():610-617. PubMed ID: 28939537
[TBL] [Abstract][Full Text] [Related]
29. Postoperative outcomes following glioblastoma resection using a robot-assisted digital surgical exoscope: a case series.
Baron RB; Lakomkin N; Schupper AJ; Nistal D; Nael K; Price G; Hadjipanayis CG
J Neurooncol; 2020 Jul; 148(3):519-527. PubMed ID: 32519286
[TBL] [Abstract][Full Text] [Related]
30. Repeat pulmonary resection for metachronous colorectal carcinoma is beneficial.
Kim AW; Faber LP; Warren WH; Saclarides TJ; Carhill AA; Basu S; Choh MS; Liptay MJ
Surgery; 2008 Oct; 144(4):712-7; discussion 717-8. PubMed ID: 18847658
[TBL] [Abstract][Full Text] [Related]
31. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study.
Gerritsen JKW; Zwarthoed RH; Kilgallon JL; Nawabi NL; Jessurun CAC; Versyck G; Pruijn KP; Fisher FL; Larivière E; Solie L; Mekary RA; Satoer DD; Schouten JW; Bos EM; Kloet A; Nandoe Tewarie R; Smith TR; Dirven CMF; De Vleeschouwer S; Broekman MLD; Vincent AJPE
Lancet Oncol; 2022 Jun; 23(6):802-817. PubMed ID: 35569489
[TBL] [Abstract][Full Text] [Related]
32. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
33. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
Quick-Weller J; Lescher S; Forster MT; Konczalla J; Seifert V; Senft C
Br J Neurosurg; 2016 Jun; 30(3):313-7. PubMed ID: 26743016
[TBL] [Abstract][Full Text] [Related]
34. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
Molinaro AM; Hervey-Jumper S; Morshed RA; Young J; Han SJ; Chunduru P; Zhang Y; Phillips JJ; Shai A; Lafontaine M; Crane J; Chandra A; Flanigan P; Jahangiri A; Cioffi G; Ostrom Q; Anderson JE; Badve C; Barnholtz-Sloan J; Sloan AE; Erickson BJ; Decker PA; Kosel ML; LaChance D; Eckel-Passow J; Jenkins R; Villanueva-Meyer J; Rice T; Wrensch M; Wiencke JK; Oberheim Bush NA; Taylor J; Butowski N; Prados M; Clarke J; Chang S; Chang E; Aghi M; Theodosopoulos P; McDermott M; Berger MS
JAMA Oncol; 2020 Apr; 6(4):495-503. PubMed ID: 32027343
[TBL] [Abstract][Full Text] [Related]
35. Is a modification of the radiotherapeutic target volume necessary after resection of glioblastomas with opening of the ventricles?
Adeberg S; Diehl C; Jung CS; Rieken S; Combs SE; Unterberg A; Debus J
J Neurooncol; 2016 May; 127(3):581-7. PubMed ID: 26830090
[TBL] [Abstract][Full Text] [Related]
36. The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
Rahman M; Abbatematteo J; De Leo EK; Kubilis PS; Vaziri S; Bova F; Sayour E; Mitchell D; Quinones-Hinojosa A
J Neurosurg; 2017 Jul; 127(1):123-131. PubMed ID: 27689459
[TBL] [Abstract][Full Text] [Related]
37. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
38. Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
Vivas-Buitrago T; Domingo RA; Tripathi S; De Biase G; Brown D; Akinduro OO; Ramos-Fresnedo A; Sabsevitz DS; Bendok BR; Sherman W; Parney IF; Jentoft ME; Middlebrooks EH; Meyer FB; Chaichana KL; Quinones-Hinojosa A
J Neurosurg; 2022 Jan; 136(1):1-8. PubMed ID: 34087795
[TBL] [Abstract][Full Text] [Related]
39. Histologic Findings at the Time of Repeat Resection Predicts Survival in Patients with Glioblastoma.
Melnick K; Miller P; Carmichael E; Wang Y; Tran D; Kresak JL; Ghiaseddin A; Rahman M
World Neurosurg; 2022 Dec; 168():e451-e459. PubMed ID: 36206964
[TBL] [Abstract][Full Text] [Related]
40. Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma.
Bagley SJ; Schwab RD; Nelson E; Viaene AN; Binder ZA; Lustig RA; O'Rourke DM; Brem S; Desai AS; Nasrallah MP
J Neurooncol; 2019 Jan; 141(2):421-429. PubMed ID: 30446903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
